STAT3 as Biologically Relevant Target in H3K27M-Mutant Diffuse Midline Glioma | Oncotarget



October 5, 2023

  • Share
  • Oncotarget published this editorial perspective on October 4, 2023 in Volume 14, entitled, “STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma” by researchers from the Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. DOI - Correspondence to - David J. Daniels - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, H3K27M, DMG, DIPG, midline glioma, STAT3 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - X - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer Research

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.